{"id":"NCT01031680","sponsor":"AstraZeneca","briefTitle":"Efficacy and Safety in Patients With Type 2 Diabetes Mellitus, Cardiovascular Disease and Hypertension","officialTitle":"A 24-week, Multicentre, Randomised, Double-blind, Age-stratified, Placebo Controlled, Phase III Study With a 80-week Extension Period to Evaluate the Efficacy and Safety of Dapagliflozin 10 mg Once Daily in Pts With T2DM, CV Disease and Hypertension Who Exhibit Inadequate Glycaemic Control on Usual Care","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-02","primaryCompletion":"2011-05","completion":"2012-12","firstPosted":"2009-12-14","resultsPosted":"2013-08-23","lastUpdate":"2013-10-29"},"enrollment":922,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus","Cardiovascular Disease","Hypertension","Inadequate Glycaemic Control"],"interventions":[{"type":"DRUG","name":"Dapagliflozin","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"PLACEBO_COMPARATOR"}],"summary":"This study is carried out to assess whether dapagliflozin lowers blood glucose, body weight and blood pressure, when added to patients existing medications and how it compares with their usual treatment without added dapagliflozin. Safety data will be collected and analysed to confirm that treatment with dapagliflozin is safe and well tolerated in patients who have diabetes, cardiovascular disease and hypertension.","primaryOutcome":{"measure":"Adjusted Mean Change in HbA1c Levels","timeFrame":"Baseline to Week 24","effectByArm":[{"arm":"Experimental","deltaMin":-0.38,"sd":null},{"arm":"Placebo Comparator","deltaMin":0.08,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"45 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":140,"countries":["United States","Argentina","Canada","Germany","Romania","Slovakia","Spain","Taiwan","Vietnam"]},"refs":{"pmids":["38770818","25852208"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":27,"n":460},"commonTop":["Hypoglycemia"]}}